EnglishChinese (Traditional)FrenchGermanJapaneseKoreanPortugueseRussianSpanish

CONTRACT DEVELOPMENT & MANUFACTURING

Technology-driven, Compliant production, Cost-effective and efficient services, providing customers with integrated services of R&D and commerical production of new chemical entities

RELIABLE SERVICE

Material sourcing, Small-scale process transfer, Pilot scale-up, Industrialization, and Document registration and Audit services

Home > Product >
CAS:1809249-37-3_Remdesivir
Remdesivir_API CAS:1809249-37-3_Remdesivir
Product Name: Remdesivir
Synonym: Remdesivir; GS-5734; GS 5734; GS5734, Prodrug of GS-441524; Prodrug of GS441524; Prodrug of GS441524;
CAS#: 1809249-37-3 
Chemical Formula: C28H36N5O8P 
Exact Mass: 601.2301 
Molecular Weight: 601.5968 
IUPAC/Chemical Name: 2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-b]pyridazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate

Application:
Remdesivir has been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus and Coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis.
 
Gilead Sciences has recently confirmed that it is demonstrating whether the experimental Ebola drug Remdesivir may cause a fight against a new coronavirus (2019-nCoV) emerging in China. The company said that "active discussions are underway with researchers and clinicians in the United States and China about the potential use of Remdesivir in therapy."
Remdesivir, also known as GS-5734, is an experimental RNA polymerase inhibitor developed by Gilead Sciences in 2014 in collaboration with the Centers for Disease Control and Prevention (CDC) and the U.S. Army Medical Institute for Infectious Diseases Anthony Fossie, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), stated in a comment on JAMA Network that SARS-CoV and MERS-CoV are being used as prototypes to develop treatment strategies for 2019-nCoV. "Broad-spectrum antivirals, such as Remdesivir, lopinavir / ritonavir and interferon, have shown promise against MERS-CoV in animal models and are evaluating their activity against 2019-nCoV," he said.

Remdesivir api manufacturer
 
 


UNICHEMIST manufacture & supply Remdesivir_API CAS:1809249-37-3_Remdesivir,if you want to buy it,please drop your inquiry to [email protected] ,we will reply you asap.If you have any custom synthesis or contract manufacturing compounds, please also feel free to contact us.



Previous:3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl(trimethoxy)silane CAS:83048-65-1 | Next:Bis(2-oxo-3-oxazolidinyl)phosphinic chloride CAS:68641-49-6
About Us Disclaimer

Factory in Henan Province
The Henan factory is located in the south of Tengda Road and the west of Gongye 3rd Road, Huaiyang District, Zhoukou City, Henan Province. The first phase covers an area of about 200 acres with a total construction area of about 170,496 square meters. It is mainly engaged in the production and sales of pharmaceutical and biological products. More than 800 acres are planned for the second phase. The company has established a stable production service system that can meet the requirements of different quality assurance systems and process conditions, and can realize small-scale process transfer, pilot scale-up, and industrialization, as well as corresponding document registration and auditing.


Factory in Shanxi Province
At the end of 2017, We invested workshop in Xinjiang County Longzhou Chemical Co., Ltd., Xinjiang County Coal Mine Park, Yuncheng, Shanxi. The first phase of the reactors were 30* 2000L~5000L, The contract output value is 50 million annually, factory has passed the audit from public listed company domestic and abroad.


Factory in Shandong Province
The Shandong production plant is located in Liaocheng City, Shandong Province. It has a production workshop covering an area of 2600m², a supporting material warehouse of 800m², a QC laboratory of 150m², and a number of 500~5000L reactors. It has successfully carried out a number of scale-up production projects. The annual output of the body is more than 200 tons.

Certain products are for research use only. Not for diagnostic or therapeutic use. Not for human use. UNICHEMIST does not sell to individuals. UNICHEMIST does not warrant that the use or sale of the products delivered under will not infringe the claims of any China or other patents covering the product itself or the use thereof in combination with other products or the operation of any process.

Featured Products
50000+ Reagents
From R&D to Pilot or Commerical Manufacturing